- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02437643
An Enhanced Protein (Dairy) Weight Loss Intervention for Dynapenic Obesity: Impact on Muscle Quality and Composition (DDYNAMO)
Study Overview
Status
Intervention / Treatment
Detailed Description
Obese older adults (≥60 yrs) with moderate functional impairment will be randomized to 1 of 2 study arms. Outcomes to be measured at 0, 3 and 6 months are as follows: Primary outcomes- (1) Muscle Quality (MQ): muscle power (time to perform ten chair rises, height of the chair, leg length, body mass, and acceleration of gravity) in relation to muscle mass (CT-scan) and (2) Muscle adipose infiltration (MAI) (CT-scan). Secondary outcomes- Bone Mineral Density (BMD; DXA scan) physical function (Short Physical Performance Battery (SPPB); 6 minute walk; 8-foot up and go; and 30 second chair stands; handgrip strength; body weight; fat mass; waist circumference; activity (accelerometers); mental health (sleep, depression, quality of life); and feasibility factors (adherence, protein intake, nutrition adequacy). BMD will only be accessed at 0 and 6 months.
Study Arms:
- Weight loss plus low-intensity exercise intervention (WL-LoEX; n = 35): Subjects follow a calorie-reduction diet for a weight loss of ≥10%, protein~0.8g/g/d. Subjects will also participate in three 30-minute low-intensity exercise sessions weekly. One serving of dairy protein/day will be provided to WL-LoEX participants.
- High protein weight loss plus low-intensity exercise intervention (PRO-WL-LoEX; n = 35): Subjects follow a calorie-reduction diet for a weight loss of ≥10%, with a high proportion of high quality protein at each meal. Intakes of > 30g of protein will be achieved three times a day by subjects in this group, with all or predominantly all from animal sources (high quality) and 60-70% of animal protein from dairy foods that will be provided. Subjects will also participate in three 30-minute low-intensity exercise sessions weekly.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Duke University Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- BMI >30;
- SPPB score of ≥4 to <10;
- GFR <45 mL/min
Exclusion Criteria:
- Body weight >495 lbs. (BodPod limits);
- estimated glomerular filtration rates (eGFR) less than 45 mL/min;
- symptomatic cardiac disease;
- receiving chemotherapy;
- hemophilia;
- presence of unstable or symptomatic life-threatening illness;
- neurological disease or disorder causing functional impairments;
- inability to walk,
- dementia;
- prescription weight loss medications;
- use of monamine oxidase inhibitors (MAOIs); or
- primary medical provider advises against participation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: WL-LoEX
10% Weight loss diet plus low intensity exercise (protein ~0.8g/kg).
Participants will be provided one serving of dairy protein daily.
|
Participants will be prescribed hypo-caloric diet prescription.
Participants will be provided dairy products: WL-LoEx will be provided 1 dairy serving per day and Pro-WL-LoEx will be provided 8 dairy servings per day.
Participants in both groups will participate in chair exercises 3 times a week.
|
|
Active Comparator: Pro-WL-LoEX
Protein-enhanced 10% Weight loss diet plus low intensity exercise (protein ~1.2 g/kg with > 30g per meal and >60% as dairy).
Participants will be provided at least 8 servings of dairy protein daily.
|
Participants will be prescribed hypo-caloric diet prescription.
Participants will be provided dairy products: WL-LoEx will be provided 1 dairy serving per day and Pro-WL-LoEx will be provided 8 dairy servings per day.
Participants in both groups will participate in chair exercises 3 times a week.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in muscle quality
Time Frame: baseline, 3 months, 6 months
|
composite score of time to perform ten chair rises, height of the chair, leg length, body mass, and acceleration of gravity in relation to muscle mass
|
baseline, 3 months, 6 months
|
|
Change in muscle adipose infiltration
Time Frame: baseline, 3 months, 6 months
|
CT-scan
|
baseline, 3 months, 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Physical Function
Time Frame: baseline, 3 months, 6 months
|
short physical performance battery score
|
baseline, 3 months, 6 months
|
|
Change in Body weight
Time Frame: baseline, 3 months, 6 months
|
change in weight
|
baseline, 3 months, 6 months
|
|
Change in lean Body Mass
Time Frame: baseline, 3 months, 6 months
|
BodPod
|
baseline, 3 months, 6 months
|
|
Change in lean Body Mass
Time Frame: baseline, 3 months, 6 months
|
DEXA
|
baseline, 3 months, 6 months
|
|
Change in fat mass
Time Frame: baseline, 3 months, 6 months
|
BodPod
|
baseline, 3 months, 6 months
|
|
Change in fat mass
Time Frame: baseline, 3 months, 6 months
|
DEXA
|
baseline, 3 months, 6 months
|
|
Change in 6-minute walk time
Time Frame: baseline, 3 months, 6 months
|
6-minute walk
|
baseline, 3 months, 6 months
|
|
Change in 8-foot up and go time
Time Frame: baseline, 3 months, 6 months
|
time it takes to complete 8-foot up and go
|
baseline, 3 months, 6 months
|
|
Change in 30 second chair stands
Time Frame: baseline, 3 months, 6 months
|
number of chair stands done in 30 seconds
|
baseline, 3 months, 6 months
|
|
Change in dietary protein intake
Time Frame: baseline, 3 months, 6 months
|
3-day food record
|
baseline, 3 months, 6 months
|
|
Change in calorie intake
Time Frame: baseline, 3 months, 6 months
|
3-day food record
|
baseline, 3 months, 6 months
|
|
Change in Bone Mineral Density
Time Frame: Baseline and 6-months
|
DEXA
|
Baseline and 6-months
|
|
Change in sleep
Time Frame: baseline, 3 months, 6 months
|
Pittsburgh sleep quality index
|
baseline, 3 months, 6 months
|
|
Change in depression
Time Frame: baseline, 3 months, 6 months
|
Center for Epidemiologic Studies Depression Scale
|
baseline, 3 months, 6 months
|
|
Change in hand grip strength
Time Frame: baseline, 3 months, 6 months
|
Jamar Hand Dynamometer
|
baseline, 3 months, 6 months
|
|
Change in physical activity
Time Frame: baseline, 3 months, 6 months
|
Community Health Activities Model Program for Seniors (CHAMPS)
|
baseline, 3 months, 6 months
|
|
Change in physical activity
Time Frame: Baseline, 3 months, 6 months
|
Actigraph - accelerometer
|
Baseline, 3 months, 6 months
|
|
Change in quality of life
Time Frame: Baseline, 3 months, 6 months
|
SF-36
|
Baseline, 3 months, 6 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Connie Bales, PhD, RD, Duke University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00057509
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on Weight Loss
-
University of VermontUniversity of Vermont Medical CenterCompletedBreast Cancer | Overweight | PostmenopausalUnited States
-
University of PittsburghCompleted
-
University of Alabama at BirminghamNational Cancer Institute (NCI)Completed
-
VA Office of Research and DevelopmentTerminatedOverweight | Obstructive Sleep ApneaUnited States
-
University of TennesseeCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Maryland Cigarette Restitution FundCompletedKidney Cancer | Breast Cancer | Rectal Cancer | Prostate Cancer | Bladder Cancer | Endometrial Cancer | Melanoma (Skin) | Gallbladder CancerUnited States
-
Boston Children's HospitalUniversity of Alabama at Birmingham; Indiana University; Baylor University; Framingham...Terminated
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Brown... and other collaboratorsRecruiting
-
University of ArkansasNational Institute on Minority Health and Health Disparities (NIMHD)Completed